 |
|
 |
Ostalo
Therapeutic Plasma Exchange in the Neurologic Intensive Care Setting: Recommendation for Clinical Practice
Petar Kes
Vanja Bašić-Kes
Nikolina Bašić-Jukić
Vida Demarin
| Puni tekst: engleski, pdf (227 KB) | str. 137-153 | citiraj | |
|
APA 6th Edition Kes, P., Bašić-Kes, V., Bašić-Jukić, N. i Demarin, V. (2012). Therapeutic Plasma Exchange in the Neurologic Intensive Care Setting: Recommendation for Clinical Practice. Acta clinica Croatica, 51 (1), 137-153. Preuzeto s https://hrcak.srce.hr/85749 MLA 8th Edition Kes, Petar, et al. "Therapeutic Plasma Exchange in the Neurologic Intensive Care Setting: Recommendation for Clinical Practice." Acta clinica Croatica, vol. 51, br. 1, 2012, str. 137-153. https://hrcak.srce.hr/85749. Citirano 16.04.2021. Chicago 17th Edition Kes, Petar, Vanja Bašić-Kes, Nikolina Bašić-Jukić i Vida Demarin. "Therapeutic Plasma Exchange in the Neurologic Intensive Care Setting: Recommendation for Clinical Practice." Acta clinica Croatica 51, br. 1 (2012): 137-153. https://hrcak.srce.hr/85749 Harvard Kes, P., et al. (2012). 'Therapeutic Plasma Exchange in the Neurologic Intensive Care Setting: Recommendation for Clinical Practice', Acta clinica Croatica, 51(1), str. 137-153. Preuzeto s: https://hrcak.srce.hr/85749 (Datum pristupa: 16.04.2021.) Vancouver Kes P, Bašić-Kes V, Bašić-Jukić N, Demarin V. Therapeutic Plasma Exchange in the Neurologic Intensive Care Setting: Recommendation for Clinical Practice. Acta clinica Croatica [Internet]. 2012 [pristupljeno 16.04.2021.];51(1):137-153. Dostupno na: https://hrcak.srce.hr/85749 IEEE P. Kes, V. Bašić-Kes, N. Bašić-Jukić i V. Demarin, "Therapeutic Plasma Exchange in the Neurologic Intensive Care Setting: Recommendation for Clinical Practice", Acta clinica Croatica, vol.51, br. 1, str. 137-153, 2012. [Online]. Dostupno na: https://hrcak.srce.hr/85749. [Citirano: 16.04.2021.] |
|||
Sažetak
Therapeutic plasma exchange (TPE ) is a well-established therapeutic procedure commonly used in many neurologic immune-mediated disorders. It is thought that the beneficial effects of TPE occur through elimination of pathognomonic autoantibodies, immune complexes, inflammatory mediators, complement components and cytokines, which play a crucial role in many kinds of neurologic autoimmune disease. In various neurologic disorders, randomized controlled studies have demonstrated the efficacy of TPE (e.g., in acute inflammatory demyelinating polyneuropathy (Guillain-Barré syndrome), chronic inflammatory demyelinating polyradiculoneuropathy, myasthenia gravis and paraproteinemic polyneuropathies). For these disorders, TPE is accepted as first-line therapy, either as a primary standalone treatment or in conjunction with other modes of treatment. Although widely used, the potential benefit of TPE in the treatment of acute disseminated encephalomyelitis, chronic focal encephalitis (Rasmussen’s encephalitis), Lambert-Eaton myasthenic syndrome, multiple sclerosis and neuromyelitis optica (Devic’s disease) is less clear. For these disorders, TPE is accepted as second-line therapy, either as a standalone treatment or in conjunction with other modes of treatment.
Ključne riječi
Acute disseminated encephalomyelitis; Acute inflammatory demyelinating polyneuropathy; Chronic focal encephalitis; Chronic inflammatory demyelinating polyradiculoneuropathy; Lambert-Eaton myasthenic syndrome; Multiple sclerosis; Myasthenia gravis; Neuromyelitis optica; Paraproteinemic polyneuropathies; Therapeutic plasma exchange
Hrčak ID: 85749
URI
https://hrcak.srce.hr/85749
Moj profil
Srce